Skip to main content

Advertisement

Log in

Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

Preoperative elevation of serum C-reactive protein (CRP) is a prognostic indicator for some malignant tumors. We investigated the clinicopathologic importance of an elevated preoperative serum CRP value in gastric carcinoma patients.

Methods

We studied the relationship between the preoperative serum CRP value and clinicopathologic characteristics in 204 patients who underwent curative resection of gastric carcinoma.

Results

The patients with preoperative CRP elevation had significantly poorer survival than those without CRP elevation (P < 0.0001). According to multivariate analysis, the factors independently associated with an unfavorable prognosis were a high preoperative CRP value (P = 0.024), lymphatic invasion (P = 0.017) and advanced tumor stage (P = 0.016).

Conclusion

Preoperative serum CRP elevation can be an independent prognostic indicator in patients with gastric carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Zimmerman MA, Selzman CH, Cothren C, Sorensen AC, Raeburn CD, Harken AH. Diagnostic implications of C-reactive protein. Arch Surg 2003;138:220–224.

    Article  PubMed  Google Scholar 

  2. Rashid SA, O’Quigley J, Axon AT, Cooper EH. Plasma protein profiles and prognosis in gastric cancer. Br J Cancer 1982;45:390–394.

    Article  PubMed  CAS  Google Scholar 

  3. Shiu YC, Lin JK, Huang CJ, Jiang JK, Wang LW, Huang HC, et al. Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum 2008;51:443–449.

    Article  PubMed  Google Scholar 

  4. Nozoe T, Mori E, Takahashi I, Ezaki T. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surg Today 2008;38:597–602.

    Article  PubMed  CAS  Google Scholar 

  5. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998;176:335–338.

    Article  PubMed  CAS  Google Scholar 

  6. Deans DA, Wigmore SJ, de Beaux AC, Paterson-Brown S, Garden OJ, Fearon KC. Clinical prognostic scoring system to aid decisionmaking in gastro-oesophageal cancer. Br J Surg 2007;94:1501–1508.

    Article  PubMed  CAS  Google Scholar 

  7. Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 2001;182:197–201.

    Article  PubMed  CAS  Google Scholar 

  8. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd English ed. Gastric Cancer 1998;1:10–24.

    Google Scholar 

  9. Senju O, Takagi Y, Uzawa R, Iwasaki Y, Suzuki T. A new immunoquantitative method by latex agglutination — application for the determination of serum C-reactive protein (CRP) and its clinical significance. J Clin Lab Immunol 1986;19:99–103.

    PubMed  CAS  Google Scholar 

  10. Du Clos TW. Function of C-reactive protein. Ann Med 2000;32:274–278.

    Article  PubMed  Google Scholar 

  11. Nozoe T, Korenaga D, Futatsugi M, Saeki H, Maehara Y, Sugimachi K. Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus — significance as a tumor marker. Cancer Lett 2003;192:89–95.

    Article  PubMed  CAS  Google Scholar 

  12. Hara M, Matsuzaki Y, Shimuzu T, Tomita M, Ayabe T, Enomoto Y, et al. Preoperative serum C-reactive protein level in non-small cell lung cancer. Anticancer Res 2007;27:3001–3004.

    PubMed  CAS  Google Scholar 

  13. Beer TM, Lalani AS, Lee S, Mori M, Eilers KM, Curd JG, et al. C-reactive protein as a prognostic marker for men with androgenindependent prostate cancer: results from the ASCENT trial. Cancer 2008;112:2377–2383.

    Article  PubMed  CAS  Google Scholar 

  14. Hefler LA, Concin N, Hofstetter G, Marth C, Mustea A, Sehouli J, et al. Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res 2008;14:710–714.

    Article  PubMed  CAS  Google Scholar 

  15. Liao WC, Lin JT, Wu CY, Huang SP, Lin MT, Wu AS, et al. Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma. Clin Cancer Res 2008;14:428–434.

    Article  PubMed  CAS  Google Scholar 

  16. Ashizawa T, Okada R, Suzuki Y, Takagi M, Yamazaki T, Sumi T, et al. Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor. Gastric Cancer 2005;8:124–131.

    Article  PubMed  CAS  Google Scholar 

  17. Forones NM, Mandowsky SV, Lourenço LG. Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer. Hepatogastroenterology 2001;48: 1199–1201.

    PubMed  CAS  Google Scholar 

  18. Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Kustrzeba-Wojcicka I, et al. Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers. Clin Chem Lab Med 2008;46:359–364.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nozoe, T., Iguchi, T., Adachi, E. et al. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer. Surg Today 41, 510–513 (2011). https://doi.org/10.1007/s00595-009-4297-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-009-4297-x

Key words

Navigation